Search

everythinglearnresearchcommunity

for

Search:↓

The study aims to create a model to predict health attributes using diverse health data from Japanese adults.

Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.

Polycystic Ovary Syndrome (PCOS) was found in 3.86% of tenth-grade girls in Guangzhou, China, with higher rates in overweight and obese girls, suggesting diagnosis should focus on hyperandrogenemia.

Androgenetic alopecia starts earlier in males than females, with different treatments, and is linked to income, education, alcohol use, and mental health.

Wearing a hijab is linked to a higher risk of hair loss.

Classical PCOS types A and B are most common and linked to higher health risks.

Androgenetic alopecia may predict metabolic syndrome, so routine screening is recommended to prevent cardiovascular issues.

Many women with PCOS in Saudi Arabia suffer from depression and anxiety.

About 61% of women who had COVID-19 experienced hair loss afterward.

The internet has accurate information on Polycystic Ovarian Syndrome, but it's not high quality or easy to read, so we need better, user-friendly resources.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Trichoscopy is useful for quickly diagnosing different types of hair loss without needing biopsies.

Many people in Saudi Arabia use multivitamins for hair loss, often without medical advice, and while some report improvements, more research is needed on their effectiveness and safe use.

Female pattern hair loss in Western India is common and often linked to metabolic syndrome.

Changes in scalp bacteria are linked to female hair loss, suggesting new treatment options.

Finger length ratios might predict risk for skin condition in males.

People with Type 2 Diabetes are more likely to have a mite infestation called Demodex folliculorum.

Pseudofolliculitis barbae is linked to higher rates of anxiety and depression.

Hair loss negatively impacts quality of life, and psychological support can help.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Hair loss in lupus patients indicates higher disease activity.

Most patients with chronic kidney disease had skin issues like paleness and dry skin, and treating these can improve their lives.

Cochrane and non-Cochrane drug safety reviews report well in PRISMA but poorly in PRISMA harms, with non-Cochrane needing improvement.

Wearing headcovers doesn't affect male-pattern hair loss severity.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

Skin problems like acne, excessive hair growth, and oily skin are common in women with PCOS and can help with early diagnosis.

Dermoscopy and trichoscopy are useful for diagnosing skin signs in Dermatomyositis.

Cochrane systematic reviews have better methodological quality than non-Cochrane ones, and improvements are needed for the latter.

Men with androgenetic alopecia, or hair loss, often have abnormal blood flow in their small blood vessels, which might be linked to inflammation and stress.